SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe

SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe

The Lancet Microbe publishes SNIPR001 Phase 1: safe, gut‑restricted, microbiome stable; Phase 1b HSCT trial >50% enrolled....

  • First-ever randomized, placebo-controlled Phase 1 trial - published in The Lancet Microbe - supports SNIPR001s safety, tolerability, and restriction to the gastrointestinal tract in healthy p… [+5605 chars]
SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe - FHMnews